Pharmaceutical counterfeiting is a growing area of public safety and national security concern. Biological medications are a growing portion of counterfeit medicines due to the high cost and opportunities for profit from these innovative drugs. Biologics are a unique target for counterfeiters in international commerce presentingunique hazards over traditional, more stable, pills. This Article explores the international biopharmaceutical supply chain and the regulatory weaknesses that compromise public health.
Bitter Biopharmaceuticals: Biologic Counterfeiting and Supply Chain Concerns,
San Diego Int'l L.J.
Available at: http://digital.sandiego.edu/ilj/vol18/iss1/6